Atlas Trials

A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder

Clinical trial NCT00411398 · COMPLETED

Trial details

NCT number
NCT00411398
Sponsor
State University of New York - Upstate Medical University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
General Anxiety Disorder, Social Anxiety Disorder
Start date
2006-12-01
Primary completion
2010-05-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.